Dr. McGilvray studied medicine at McGill University, graduating in 1993. He entered the General Surgery training program at the University of Toronto that same year. During his residency, he undertook graduate studies in Dr. Ori Rotstein’s laboratory and obtained a PhD in Cell Biology. He became a Fellow of the Royal College of Physicians and Surgeons of Canada in 2001. After a clinical fellowship in Transplantation and Hepatobiliary Surgery at the Toronto General Hospital, he began his appointment at the University Health Network in 2003. He is currently an Associate Professor in the Department of Surgery at the University of Toronto.
- Diseases of the liver, particularly viral hepatitis
- Transplant immunology
- Hepatic ischemia/reperfusion injury
- Vascular reconstructive techniques for locally advanced liver and pancreas cancer
- Applicability of transplantation to oncology diagnoses
Expert Rev Proteomics. 2013 Jun;10(3):275-87
Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
Transpl Int. 2013 Aug;26(8):780-7
Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
Clin Transplant. 2013 Jul-Aug;27(4):503-9
Normothermic acellular ex vivo liver perfusion reduces liver and bile duct injury of pig livers retrieved after cardiac death.
Am J Transplant. 2013 Jun;13(6):1441-9
Hepatology. 2013 Jul;58(1):120-7
Dissecting pseudoaneurysm of the proper hepatic artery repaired by primary anastomosis: a case report.
Case Rep Surg. 2012;2012:804919
Pancreas-after-kidney versus synchronous pancreas-kidney transplantation: comparison of intermediate-term results.
Transplantation. 2013 Feb 15;95(3):489-94
Living vs. deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis.
Clin Transplant. 2013 Jan-Feb;27(1):140-7
Protective effects of long pentraxin PTX3 on lung injury in a severe acute respiratory syndrome model in mice.
Lab Invest. 2012 Sep;92(9):1285-96
Routine induction therapy in living donor liver transplantation prevents rejection but may promote recurrence of hepatitis C.
Transplant Proc. 2012 Jun;44(5):1351-6
Scientist, Toronto General Hospital Research Institute (TGHRI)
Associate Professor, Department of Surgery, Faculty of Medicine, University of Toronto